1118 Codiak
BioCentury & Getty Images

Product Development

Preclinical POC for Codiak’s IL-12 therapy highlight retention benefits of exosomes

Nov 19, 2020 | 2:17 AM GMT

Data presented at

Read the full 268 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE